Previous close | 4.9600 |
Open | 5.1000 |
Bid | 4.8500 x 400 |
Ask | 4.8900 x 200 |
Day's range | 4.8100 - 5.2600 |
52-week range | 2.1300 - 7.7300 |
Volume | |
Avg. volume | 585,132 |
Market cap | 234.441M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 10.80 |
EPS (TTM) | 0.4500 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.33 |
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16. PBYI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Camilla, […]
Puma Biotechnology (PBYI) reports narrower-than-expected first-quarter 2024 loss. The company maintains its revenue guidance for 2024.
Insights into Puma Biotechnology's Q1 2024 earnings, strategic initiatives, and future outlook amidst fluctuating revenues and expanding global presence.